Clinical trial data from research into tuberculosis, the world’s leading infectious killer, will be shared with researchers to help the development of new treatments.
St George’s, University of London have combined with the Critical Path Institute, the Special Programme for Research and Training in Tropical Diseases and TB Alliance to launch the data sharing program, called the TB-Platform for Aggregation of Clinical TB Studies (TB-PACTS).
The data available will include demographic information, medication information, dose/concentration information and outcomes data. It can be accessed and analysed in aggregate or filtered and viewed as individual records.
"This is an extremely important initiative, of which St. George’s is a founding member," said Dr. Amina Jindani, who leads the International Consortium for Trials of Chemotherapeutic Agents in Tuberculosis (INTERTB) at St. George’s, University of London.
“Data sharing will prevent the duplication of clinical research and facilitate the funding of trials critical to the eventual elimination of tuberculosis.
"INTERTB has much to contribute to TB-PACTS, both from past and future clinical trials of tuberculosis.”
Researchers applying for access must agree to the Terms and Conditions for Use of the TB-PACTS data platform and submit an online application form to request access to the data platform. Visit http://c-path.org/programs/tb-pacts/ for more information.